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Comparison of CT-Guided Sclerotherapy
with Using 95% Ethanol and 20%
Hypertonic Saline for Managing Simple
Renal Cyst
Objective: We wanted to compare the efficacies of 95% ethanol and 20%
hypertonic saline (HS) sclerotherapies that were performed in a single session
under CT guidance for the management of simple renal cysts. 
Materials and Methods: A prospective series of 74 consecutive patients (aver-
age age: 57.6  8.1 years) with simple renal cysts were enrolled in this study.
They were randomized into two groups and 95% ethanol or 20% HS, respective-
ly, corresponding to 25% of the aspiration volume, was injected. Treatment suc-
cess was determined six months later with follow-up clinical evaluation and per-
forming ultrasonography. 
Results: The sclerotherapy was accepted as technically successful without
major complications in all except two patients who were excluded because of a
communication between the simple renal cyst and the pelvicalyceal collecting
system. Thirty-six patients in the ethanol group received sclerotherapy with 95%
ethanol and 36 patients in the HS group underwent sclerotherapy with 20% HS.
The complete regression ratio of the ethanol group was significantly higher (94%
versus 72%, respectively) than that of the HS group. There was one patient with
partial regression in each group. The failure ratio of the ethanol group was signifi-
cantly lower (3% versus 25%, respectively) than that of the HS group. 
Conclusion: Ethanol sclerotherapy under CT guidance is a successful and
safe procedure and it can be used for the treatment of simple renal cysts.
Sclerotherapy with 95% ethanol is more effective than 20% HS sclerotherapy.
Sclerotherapy with HS may be an option for patients preferring to undergo a less
painful treatment procedure.
imple renal cysts are the most common renal masses, and they account
for approximately 65 to 70% of all of them (1). They often occur in
patients over the age of 50 as has been determined with performing
postmortem examination or renal ultrasonography (US) (2, 3). Simple renal cysts are
often incidentally discovered on US, CT or urography examinations that are
performed for urinary tract problems or other abdominal problems. The characteristic
appearance of simple renal cysts on US, CT and magnetic resonance imaging allows
the radiologist to make an accurate diagnosis. US is commonly used to exclude the
possibility of benign or malignant pathology because the kidney is readily accessible
for US examination (4).
A small proportion of simple renal cysts may be associated with symptoms, of which
pain is the commonest. Hematuria, hypertension, pelvicalyceal obstruction and cyst
rupture are less common symptoms (2). When cysts are very large, they may produce
the mechanical effects of a space-occupying lesion. Percutaneous or surgical interven-
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Stion is considered necessary only when the cyst produces
symptoms such as significant pain, an abdominal mass,
hematuria, calyceal obstruction and/or hypertension
secondary to renal segmental ischemia (5 8).
Symptomatic renal cysts can be treated by percutaneous
aspiration, with or without the injection of sclerosants, and
by open or laparoscopic surgery (9 11). For the sympto-
matic cases, treatment of the cyst is usually accompanied
by remission of the symptoms (12). The decortication of
peripheral and peripelvic cysts via laparoscopy is a safe,
minimally invasive and effective treatment for sympto-
matic renal cysts, and this method has a more durable
response than that of open surgery (13), yet laproscopy is
costly and it must be performed under general anesthesia.
On the other hand, percutaneous aspiration and sclerother-
apy are minimally invasive options. The data that’s
currently available suggests that ethanol sclerotherapy for
treating simple renal cysts has not yet been performed with
a standardized method (12). There is no consensus in the
scientific literature about the best way to treat simple renal
cysts with sclerotherapy (8, 12, 14 16). There have been
several studies that have focused on patients with cystic
hydatid disease of the liver and who were treated with the
percutaneous aspiration and injection of hypertonic saline
(17 19). There have been no studies that have evaluated
the use of hypertonic saline for the management of simple
renal cysts.
The aim of this study was to compare the efficacies of
95% ethanol and 20% hypertonic saline sclerotherapies
that were performed during a single-session for the
management of symptomatic simple renal cysts. 
MATERIALS AND METHODS
Patients
Written informed consent was obtained from each
subject, and our Human Ethics Committee approved the
study protocol. A prospective series of 74 consecutive
patients (44 males and 30 females) who presented with
symptomatic simple renal cyst were enrolled in this study
to undergo sclerotherapy. These patients were seen
between July 2002 and July 2005 at our hospital, and their
average age was 57.6 8.1 years (age range: 40 72
years). The causes of referral to our department were flank
pain in 67 patients, hydronephrosis and flank pain in two
patients and examining the patient to reassure them due to
the increasing cyst size in five patients. All the patients
presented with flank pain and these symptoms were
present for five to 13 months (mean 7 months) prior to
admssion. For patients to be eligible for the study, their
flank pain had to be non-colicky, ipsilateral to the cyst and
not related to posture. Other causes of flank pain were
excluded by the urologic evaluation that was done before
referral to our department. The exclusion criteria were
previous treatments for the renal cyst except for oral
paracetamol or nonsteroidal anti-inflammatory analgesics,
a communication between a simple renal cyst and the
pelvicalyceal collecting system, abnormal renal function,
polycystic or cystic dysplastic kidneys, those disorders that
could possibly account for the presence of cysts (tuberous
sclerosis or a previous malignancy), and peripelvic simple
renal cysts.
A simple renal cyst was diagnosed when it satisfied the
criteria of Bosniak (20, 21). The diagnosis was obtained by
abdominal US, and this was followed by a CT scan only
when the visualization was inadequate on the US scanning
performed by our study’s radiologists. CT scan was used
for five patients because of the inadequate US imaging.
The US criteria for the diagnosis of a simple renal cyst
included 1) a spherical or ovoid shape, 2) the absence of
internal echoes, 3) the presence of a thin, smooth wall that
was separate from the surrounding parenchyma and 4)
enhancement of the posterior wall that indicated there was
transmission of US through the water-filled cyst with no
calcification, no septa and no Doppler signals from within
the cyst (22). The diagnosis of a simple renal cyst was
made on the basis of the typical radiological findings with
surrounding normal renal parenchyma, normal renal
function and no associated systemic illnesses or disorders.
The volume of the cyst was estimated by US with multiply-
ing 3 diameters by the constant 0.5236 and also with
considering that the cyst’s shape resembled a sphere. We
used the following CT criteria for a renal mass that was
called a Bosniak class I cyst: a uniform cyst density of no
greater than 20 HU (the assigned density of water was 0
HU, and the cysts’ density ranged from  20 to +20 HU
[23]), no enhancement of the mass on the CT images
obtained after the administration of contrast medium (i.e.,
no increase in the Hounsfield units), and a round or oval
shape with no perceptible wall (24). 
Procedures
The sclerotherapy was performed under CT guidance on
an outpatient basis. The patients were placed in the prone
position and local anesthesia was achieved with 2%
lidocaine hydrochloride that was applied to the puncture
site. The patient was given nothing by mouth for 4 8
hours prior to the procedure. Prophylactic antibiotics were
administered 60 minutes prior to the procedure and they
were continued for at least 24 hours after the procedure.
For all the patients, their coagulopathies were corrected
prior to the procedure to decrease the chance of develop-
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with bleeding tendencies, including those who were taking
anticoagulants, did not undergo sclerotherapy until their
clotting parameters were brought within normal limits,
when possible. A pigtail catheter 5.4-Fr (PBN Medicals,
Denmark) was inserted with using a trocar-catheter system
under CT guidance (Figs. 1A, B). The cyst fluid was
aspirated as completely as possible and it was sent to the
laboratory for cytologic and biochemical examination. The
total amount of the aspirated fluid was measured to record
the cyst’s volume. The cyst was then filled with a half-and-
half mixture of water-soluble contrast medium (Telebrix
35 [350 mg iodine/ml], Guerbet Laboratories, Aulnay-
sous-Bois, France) with normal saline. For patients who
were undergoing sclerotherapy, contrast medium was
instilled into the cyst to ensure that there was no communi-
cation with the pelvicalyceal collecting system, to exclude
any leakage from the puncture site into the retroperitoneal
cavity and to determine the presence of extravasation (Fig.
1C). The patients were then randomized into the ethanol
and hypertonic saline groups; 95% ethanol or 20%
hypertonic saline, respectively, which corresponded to
75% of the aspiration volume, was injected through the
catheter into the cyst and this was left in place for 20
minutes. However, for a large cyst greater than 400 ml, the
amount of sclerosants was limited to 100 ml to avoid
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Fig. 1. Representative CT images of a 53-year-old male patient with a simple renal cyst. 
A. The simple renal cyst before aspiration. 
B. A 5.4-Fr pigtail catheter was inserted into the cyst. 
C. Contrast medium is instilled into the cyst to ensure that there was no communication with the pelvicalyceal collecting system, to
exclude any leakage from the puncture site into the retroperitoneal cavity and to determine the presence of extravasation. 
D. The cyst disappeared after successful ethanol sclerotherapy.
CDsystemic side effects. Before removal of the ethanol or
hypertonic saline, the patients were placed in the prone,
supine, and lateral decubitus positions for a minimum of 5
minutes each to allow adequate contact of the ethanol with
all areas of the cyst wall (25). The ethanol or hypertonic
saline was then removed and the pigtail catheter was
removed (Fig. 1D). Sclerotherapy was deemed as techni-
cally successful if the procedure went uneventfully without
any complication. 
Follow-up
Evaluations that included asking questions about residual
pain, a physical examination and routine abdominal US
performed by the same radiologist who performed the
puncture, were done at one, three and six months after
treatment, with special attention being given to the
segment of the kidney in which the treated cyst had been
located. CT imaging after sclerotherapy was required for
three patients because of inadequate US visualization of
the kidneys.
Six months after sclerotherapy with performing follow-
up clinical and US evaluations, the treatment success was
evaluated according to regression of the cyst and the
improvement of the previous clinical symptoms and
findings. Disappearance of the renal cyst with the absence
of the previous clinical symptoms and findings was consid-
ered as complete regression. A reduction in the volume of
the cyst of more than half the volume before sclerotherapy
was performed when there was partial improvement of the
previous clinical symptoms and the findings were consid-
ered as partial regression. Treatment was accepted to have
failed when the cyst recurred to more than half the
previous volume before sclerotherapy and/or when no
there was improvement of the previous clinical symptoms
and findings. After failure of sclerotherapy, the patients
underwent sclerotherapy again with the same sclerosant
for up to three times if they had persistent flank pain.
Statistical Analysis
The volume of the cysts and the presence of complete or
partial regression and failure at the follow-up were all
recorded. The presence of pain during filling the cyst with
sclerosant and also the presence of pain after the
procedure were also recorded. The cystic volumes of the
ethanol and hypertonic saline groups were analyzed with
the Mann-Whitney U test. The complete regression and
failure ratios of the ethanol and hypertonic saline groups
were analyzed with the 
2 test.
RESULTS
The sclerotherapy was technically successful in all but
two patients, and these patients were excluded because a
communication existed between their simple renal cyst and
the pelvicalyceal collecting system. Of the remaining 72
patients, 36 patients in the ethanol group received
sclerotherapy with 95% ethanol, and 36 patients in the
hypertonic saline group underwent sclerotherapy with
20% hypertonic saline. There were no major complications
in the study groups and no signs of intoxication with the
use of sclerosants. There were no significant differences
between the types and volumes of the administered and
removed sclerosants in the ethanol and hypertonic saline
groups (p = 0.311 and p = 0.471, respectively). The
cytology examination of the fluid was negative for
neoplastic cells in all the patients, and biochemical analysis
of the cystic fluid showed findings similar to those of the
corresponding plasma.
Figure 2 presents the volume of the simple renal cysts in
the ethanol and hypertonic saline groups. There was no
significant difference between the ethanol and hypertonic
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Fig. 2. Scatter dot plot with median line graphics of the volume of
the simple renal cysts in the ethanol and hypertonic saline
groups. There was no significant difference of the cyst volume
between the study groups (p = 0.995).saline groups for the median volume of the simple renal
cysts (165 [52 480] vs. 178 [42 520] cm
3, respectively, p
= 0.995).
Figure 3 displays the number of patients in the ethanol
and hypertonic saline groups with complete and partial
regression, and those with failure at the follow-up six
months after sclerotherapy. The number of patients of the
ethanol and hypertonic saline groups with complete regres-
sion were 34 and 26, respectively. The complete regression
ratio of the ethanol group was significantly higher (94%
vs. 72%, respectively) than that of the hypertonic saline
group (p = 0.024). There was one patient each with partial
regression in both the ethanol and hypertonic saline
groups. The partial regression ratios of the ethanol and
hypertonic saline groups were similar (3% vs. 3%, respec-
tively). The number of failures of the ethanol and
hypertonic saline groups was one and nine, respectively.
The failure ratio of the ethanol group was significantly
lower (3% vs. 25%, respectively) than that of the
hypertonic saline group (p = 0.014).
After failure of the sclerotherapy, the procedure was
repeated with the same sclerosant because of persistent
flank pain. The procedure was repeated one more time in
one patient in the ethanol group and one more time in five
patient, two more times in two patient and three more
times in two patient in the hypertonic saline group. At the
end of the study, the flank pain was controlled in all the
patients with repeated sclerotherapies. Complete regres-
sion was obtained for the repeatedly treated patient in the
ethanol group and for the seven repeatedly treated
patients in the hypertonic saline group. Partial regression
was obtained in two of the nine patients who required
repeated sclerotherapy in the hypertonic saline group.
There were no other serious complications after therapy
in the study groups. During the sclerotheraphy, ten
patients in the ethanol group developed mild flank pain
that required medical management with an oral
nonsteroidal anti-inflammatory drug during the filling of
the cystic cavity with the sclerosant. There was no pain
during the filling of sclerosant in the hypertonic saline
group.
DISCUSSION
Simple renal cysts are by definition unilocular, they do
not communicate with the collecting system, they occur in
a kidney that is otherwise normal and they have an epithe-
lial lining that contains no renal elements. The vast
majority of simple cysts encountered in clinical practice
develop in otherwise normal kidneys and these cysts are
now considered to be acquired lesion, and the age-
dependence of cysts has been detected in several studies as
evidence in favor of this concept (26). These occur as
multiple or single, usually cortical, cystic spaces that vary
widely in diameter. They are commonly 1 to 5 cm, but
they may reach 10 cm or more in size.
Although the vast majority of simple renal cysts are
entirely asymptomatic and do not require any treatment,
intervention is needed when they are symptomatic and
cause obstruction of the urinary tract. Simple renal cyst
that develop adjacent to the renal hilum can cause flank
pain, abdominal pain, hematuria, recurrent urinary
infections, hypertension, polycythemia and/or obstructive
uropathy (6, 27). Spontaneous, iatrogenic or traumatic
rupture of a large renal cyst will also cause hematuria or
pain. The first line of therapy for pain secondary to benign
renal cysts is medical management with nonsteroidal anti-
inflammatory agents or narcotics. When this therapy is
insufficient or other symptoms occur, then decompression
may be indicated. The treatment options include percuta-
neous aspiration with or without sclerosis, percutaneous
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Fig. 3. The number of patients, with complete and partial regres-
sion and failure at six months follow-up after sclerotherapy, in the
ethanol and hypertonic saline groups. Their percentages are also
presented.
aP = 0.024 vs. the complete regression ratio of the hypertonic
saline group with using Fisher’s exact test.
bP = 0.014 vs.  the failure ratio of the hypertonic saline group with
using Fisher’s exact test.resection and fulguration or marsupialization, uretero-
scopic cyst marsupialization, laparoscopic or retroperito-
neoscopic resection, or open surgical resection (28). Should
medical management fail for symptomatic peripheral renal
cysts, then aspiration and sclerotherapy are preferred as
the initial therapy unless these procedures are contraindi-
cated by the cyst size or complexity due to the risk of
obstructing the collecting system (29).
With modern imaging methods, most renal cysts are
aspirated as part of the therapeutic process in symptomatic
patients. To improve the efficacy, several sclerosant agents
are currently used to injure the cyst wall cells, which are
responsible for the fluid dynamics of the cyst (6). The
inflammation induced by the sclerosant leads to adhesion
of the walls and reduction or resolution of the renal cyst.
Ethanol is the most widely used among the available
sclerosant agents (7, 8, 13). Ethanol might destroy the
epithelial wall of the cyst without damaging the adjacent
renal parenchyma because its penetration through the
fibrous capsule only occurs after 4 12 hr (30). There are
published studies related to the successful use of
hypertonic saline sclerotherapy in patients with hydatid
liver cysts as a primary treatment (31, 32). Kabaalioglu et
al. (33) reported a case of 6-year-old girl with a sympto-
matic renal cyst, and she underwent successful percuta-
neous aspiration and sclerotherapy with hypertonic saline
under US guidance. They suggested that US- or CT-guided
percutaneous sclerotherapy should always be considered
before surgery.
Ethanol sclerotherapy has been reported to be successful
via performing multi-session treatment with placement of a
pigtail catheter inside the cyst for repeated instillation and
removal of the alcohol (10). Chung et al. (8) reported that
multiple sessions of sclerotherapy are better than a single
injection of sclerosant for reducing the recurrence of simple
renal cysts. Falci-Junior et al. (12) suggested that the
complete disappearance of the cyst might take as long as
six months; therefore, an abdominal US examination that
revealed the residual cyst during this period did not signify
failure or recurrence. They also reported that six months
after single-session sclerotherapy, the procedure might be
safely repeated to treat any symptomatic cyst that has
recurred. Akinci et al. (14) assessed the efficacy and long-
term results of single-session ethanol sclerotherapy for
treating simple renal cysts. They performed the sclerother-
apy procedures with the guidance via fluoroscopy and US
for 98 simple renal cysts. In that study, the average
reduction of the cyst volume was 93% at the end of the
first year and the cysts disappeared completely in 17
(17.5%) patients. After the procedure, improvement of the
flank pain was noted in 67 (90%) patients. Sixty-one
(82%) patients were free of pain and the pain decreased in
six (8%) of them. Second intervention was required in two
patients (2%) due to recurrence of cysts and the related
symptoms. One (1%) patient had a small retroperitoneal
hematoma that resolved spontaneously and in another
patient (1%), spontaneous hemorrhage was detected in the
cyst one year after the procedure. 
In this study, single-session percutaneous sclerotherapy
was preferred since it was a good option for treating
symptomatic renal cysts and it was a highly effective
procedure that offered the benefits of a less-invasive
approach. Multi-session sclerotherapy is a more time
consuming procedure than single-session sclerotherapy;
therefore, its morbidity rate may be high because of
repeated procedures (13). CT and US are alternative
image-guidance systems that are used during percutaneous
sclerotherapy for simple renal cyst. We preferred CT-
guidance during sclerotherapy because of its advantages
for determining the presence of a communication between
the simple renal cyst and the pelvicalyceal collecting
system after filling the cyst with contrast medium, for
exclusion of any leakage from the puncture site into the
retroperitoneal cavity and for determining the presence of
extravasation.
Okeke et al. (6) reported that laparoscopic de-roofing of
the cyst is a more effective treatment than single-session
sclerotherapy when a symptomatic cyst is established and
when definitive treatment of a cyst is indicated. On the
long term follow up (mean: 17 months, range: 12 23
months), pain recurred in all five patients who presented
with pain and who also underwent sclerotherapy. The high
recurrence rate for sclerotherapy might be due to the
lower ethanol volume, which was a maximum of 75 ml
and 20% of the cyst volume. Lin et al. (34) compared the
therapeutic results of the 2- and 4-hr retention techniques
during ethanol sclerotherapy with a single-session single-
injection technique for treating simple renal cysts. In that
study after complete aspiration of the cystic fluid, 95%
ethanol was injected into the cyst and it was retained for 4
hr in 14 cysts and for 2 hr in 22 cysts. They found that the
average maximal diameter and aspirated volume of the
cysts were 8.3 cm and 223 ml in the 2-hr retention group
and 7.9 cm and 167 ml in the 4-hr retention group, respec-
tively. They regularly followed up the patients by perform-
ing US, CT or both at 3-month to 6-month intervals for at
least one year. They concluded that the single-session,
prolonged ethanol-retention technique is safe and effica-
cious for the treatment of renal cysts and there was no
difference in therapeutic efficacy between the 2- and 4-hr
ethanol-retention techniques.
Gasparini et al. (16) evaluated the efficacy of pure
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treated 14 patients who had renal cysts with a mean
diameter of 10 cm (range: 5 15 cm). They used the
following technique: US-guided percutaneous puncture
with an 18-gauge needle, positioning of a 5-Fr catheter,
complete cyst fluid aspiration, injection of a volume of
pure alcohol equal to 15% of the initial cyst volume and
alcohol aspiration after 90 min. They repeated the
procedure eight times within five days. Their patients were
followed up by US and/or CT scan for one year. After the
study, all of their patients had become symptom free.
Follow-up showed a progressive reduction of the cyst
diameter in all cases. Only three cysts (in 2 patients and the
cystic diameters were < 2 cm) persisted after 12 months.
No significant complications were observed. They
concluded that injections of pure ethanol into renal cysts
and repeated for five days were effective for eliminating
recurrences and the related symptoms. They did not record
any significant complications. They suggested that pure
ethanol sclerotherapy could be the first-choice procedure
for the treatment of renal cysts instead of surgical manage-
ments, and this was because of the good results and the
low cost of ethanol.
Percutaneous sclerotherapy is rarely associated with
significant complications. We had no major complications
after sclerotherapy, which is similar to the reports of other
authors who found no major complications or alcohol
intoxication (10, 13, 15, 16, 34). However, intense pain
during filling of cysts with alcohol was reported by De
Dominicis et al. (35) in a few patients who were unable to
tolerate the procedure. Okeke et al. (6) found instant
severe pain with a radicular distribution after ethanol
injection for a painless cyst that presented as a renal mass.
In our study, ten patients had transient mild flank pain that
required medical management with an oral nonsteroidal
anti-inflammatory drug during filling the cyst with 95%
ethanol. The patients experienced n no pain during filling
with 20% hypertonic saline. 
The optimum agent for renal cyst sclerotherapy remains
to be determined. Alcohol at a 95% concentration is the
most commonly used sclerosing material for cyst ablation
(15, 34), and 99.8% alchohol is commonly used too (16).
Several factors for achieving sucessful renal cyst sclerother-
apy with alcohol require optimization, such as the concen-
tration of alcohol (95% or 99%), its volume in relation to
the cystic volume, the duration of sclerotherapy per
session, the number of injections required in relation to the
cystic volume and whether continuous drainage is needed
before and after sclerotherapy. In our study, the alcohol
was retained in the cyst for 20 minutes to expedite the
destroying action on the cyst epithelium without the
alcohol penetrating the renal parenchyma or entering the
circulation. A small-caliber pigtail catheter was used in our
patients, with no tract dilatation, and there was no damage
to the collecting system or adjacent organs. Single-session
percutaneous 95% ethanol or 20% hypertonic saline
sclerotherapy with CT guidance can be used for the
management of simple renal cysts, and the technical
success rate is close to 100%. There were no major compli-
cations in our study population and no signs of intoxication
with the use of sclerosant agents. In the same clinical
settings, 20% hypertonic saline sclerotherapy was not as
successful as 95% ethanol sclerotherapy, but it may be an
alternative option for patients who prefer a less painful
procedure. 
Our results suggest that CT-guided sclerotherapy with
95% ethanol in a single-session, and according to the
protocol described in this study, is preferable as a first
therapeutic option. Although the efficacy of 20%
hypertonic saline sclerotherapy in our study was lower
than that of the 95% ethanol sclerotherapy, 20%
hypertonic saline may have a place in the armory of
interventional radiologists for the managing symptomatic
simple renal cysts. Further study and follow-up is needed
to assess the long-term effects of 20% hypertonic saline
sclerotherapy on the outcome of symptomatic simple renal
cyst to determine the duration of pain for these procedures
and the rates of cyst recurrence.
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